News

A member of the Iproteos team has received an UdeM Fellowship to participate in the Fourth Summer School of Medicines (SSM4) taking place in Montreal throughout July 2-13

Iproteos attended at the “Non-Clinical Drug Safety Evaluation and Drug Development - A comprehensive Explanation of the Non-Clinical Development of Drugs and Biologics" course organized by SiTec PharmaBio and directed by Dr. Shayne C. Gad (GAD Consulting Services), which took place at Barcelona Science Park from May 14^th to May 16^th 2012.

Iproteos has been selected as one of the finalists presenting their business project at the BIOCHEM Accelerator Forum, which takes place next June in Frankfurt during the ACHEMA 2012 fair in the frame of the BiobasedWorld

http://www.biochem-project.eu/index.php?page=accelerator/frankfurt

Iproteos is mentioned in the El Periódico monographic supplement "Impulso empresarial" from April 27th 2012 El Periodico Supplement Newspaper

Iproteos is present at the 7th International Symposium on Neuroprotection and Neurorepair 2012 in Potsdam (Germany) from May 2nd to May 5th, joining experts in the field of stroke as well as Parkinson’s and  Alzheimer’s disease to discuss recent scientific findings.

Iproteos founder Prof. Ernest Giralt was awarded the National Research Award 2011 by the Spanish Ministry of Science. He was recognized in the category of Science and Technology for his contributions to the design, synthesis, controlled modification and structure of peptides and proteins, as well as for his contributions to advancing the study of the function of proteins involved in the development of Alzheimer’s disease and schizophrenia, and more recently for the use of peptides in nanobiotechnology to create remote-controlled drugs.